Literature DB >> 12115197

Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events.

Corinne Schiltz1, F Lioté, F Prudhommeaux, A Meunier, R Champy, J Callebert, T Bardin.   

Abstract

OBJECTIVE: To quantify the inflammatory cell response in rat air pouch pseudosynovial membrane during monosodium urate monohydrate (MSU) crystal-induced inflammation.
METHODS: In the rat air-pouch model, we used a computer-assisted histomorphometric method to quantify cell distributions, based on cell linear densities, in histologic sections of membranes from pouches injected with MSU or saline. The volume, white blood cell (WBC) count, and histamine content of the pouch exudates were determined at several time points.
RESULTS: Injection of 10 mg of MSU crystals into the pouch produced an acute exudate. After peaking at 24 hours, the exudate volume and WBC count decreased spontaneously over the next 3 days, simulating the self-limited course of acute gout. Membrane thickness followed a parallel course. Membrane polymorphonuclear cell (PMN) linear densities were closely correlated with exudate WBC counts, suggesting PMN recruitment from the subintimal synovial membrane. Both monocyte/macrophage and mast cell linear densities increased in the subintimal layer 2 hours after crystal injection (P = 0.038 and P = 0.03, respectively, versus controls), whereas PMN linear densities showed 2 peaks, one at 4 hours and the other 24 hours. The exudate histamine content peaked 6 hours after crystal injection, when mast cell linear densities were minimal in the membranes, suggesting mast cell degranulation.
CONCLUSION: An increase in monocyte/macrophage and mast cell densities in the membrane preceded the PMN influx in the pouch membrane and exudate, suggesting that mast cells may be involved in the early phase of MSU crystal-induced inflammation, at least in this rat model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115197     DOI: 10.1002/art.10326

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

Review 1.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

Review 2.  [The etiology and management of gout].

Authors:  B Pazár Maldonado; A So
Journal:  Z Rheumatol       Date:  2012-02       Impact factor: 1.372

3.  Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation.

Authors:  Monica Guma; Lisa Ronacher; Ru Liu-Bryan; Shinji Takai; Michael Karin; Maripat Corr
Journal:  Arthritis Rheum       Date:  2009-12

4.  [Crystal-induced activation of the inflammasome: gout and pseudogout].

Authors:  M Winzer; A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 5.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

6.  High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals.

Authors:  Anna Scanu; Francesca Oliviero; Lyssia Gruaz; Paolo Sfriso; Assunta Pozzuoli; Federica Frezzato; Carlo Agostini; Danielle Burger; Leonardo Punzi
Journal:  Arthritis Res Ther       Date:  2010-02-11       Impact factor: 5.156

Review 7.  Mechanisms of inflammation in gout.

Authors:  Nathalie Busso; Alexander So
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

Review 8.  Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.

Authors:  Bruce N Cronstein; Prashanth Sunkureddi
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

Review 9.  Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.

Authors:  Yael Sharon; Naomi Schlesinger
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 10.  Hyperuricemia and gout.

Authors:  Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.